Development of Zalfermin, a Long-Acting Proteolytically Stabilized FGF21 Analog.

MLA

Sass-Ørum, Kristian, et al. “Development of Zalfermin, a Long-Acting Proteolytically Stabilized FGF21 Analog.” Journal of Medicinal Chemistry, vol. 67, no. 14, July 2024, pp. 11769–88. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.4c00391.

APA

Sass-Ørum, K., Tagmose, T. M., Olsen, J., Sjölander, A., Wahlund, P.-O., Han, D., Vegge, A., Reedtz-Runge, S., Wang, Z., Gao, X., Wieczorek, B., Lamberth, K., Lykkegaard, K., Nielsen, P. K., Thøgersen, H., Yu, M., Wang, J., Drustrup, J., Zhang, X., … Andersen, B. (2024). Development of Zalfermin, a Long-Acting Proteolytically Stabilized FGF21 Analog. Journal of Medicinal Chemistry, 67(14), 11769–11788. https://doi.org/10.1021/acs.jmedchem.4c00391

Chicago

Sass-Ørum, Kristian, Tina Møller Tagmose, Jørgen Olsen, Annika Sjölander, Per-Olof Wahlund, Dan Han, Andreas Vegge, et al. 2024. “Development of Zalfermin, a Long-Acting Proteolytically Stabilized FGF21 Analog.” Journal of Medicinal Chemistry 67 (14): 11769–88. doi:10.1021/acs.jmedchem.4c00391.